Rapamycin-eluting Single and Double Stenting on Serum Markers in Coronary Bifurcation Lesions

J Coll Physicians Surg Pak. 2020 Feb;30(2):222-224. doi: 10.29271/jcpsp.2020.02.222.

Abstract

The objective of study was to compare effects of rapamycin-eluting single and double stenting on serum markers like high sensitivity C-reactive protein (hs-CRP), tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), interleukin 8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1) in patients with coronary bifurcation lesions. It was an experimental study carried out from April 2016 to July 2017. One hundred and twenty-six patients were divided into two equal groups according to different treatment regimens. Group A was treated with rapamycin-eluting single stenting and group B with rapamycin-eluting double stenting. Three months after operation, hs-CRP, TNF-α, IL-6, IL-8 and MCP-1 levels in group B were lower than those in group A (p=0.010, p <0.001, p <0.001, p <0.001 and p <0.001, respectively). After one year of follow-up, rate of intrasegmental restenosis of branch vessels was higher in group A than in group B (p=0.011). Compared with rapamycin-eluting single stenting, rapamycin-eluting double stenting may regulate more effectively the above serum markers levels, reduce the incidence of intrasegmental restenosis of branch vessels.

MeSH terms

  • Aged
  • Angioplasty, Balloon, Coronary / methods*
  • Biomarkers
  • C-Reactive Protein / metabolism*
  • Chemokine CCL2 / blood*
  • Coronary Angiography
  • Coronary Stenosis / blood
  • Coronary Stenosis / diagnosis
  • Coronary Stenosis / surgery*
  • Coronary Vessels / diagnostic imaging
  • Coronary Vessels / surgery*
  • Cytokines / blood*
  • Drug-Eluting Stents
  • Female
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Male
  • Middle Aged
  • Sirolimus / pharmacology*

Substances

  • Biomarkers
  • CCL2 protein, human
  • Chemokine CCL2
  • Cytokines
  • Immunosuppressive Agents
  • C-Reactive Protein
  • Sirolimus